Theriva Biologics, Inc.

TOVX ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
8-K	Nov 2, 2026	FORM 8-K
DEF 14A	Oct 20, 2026	DEF 14A
PRE 14A	Oct 9, 2026	PRE 14A
S-8	Aug 24, 2026	FORM S-8
10-Q	Aug 11, 2026	10-Q
8-K	Aug 11, 2026	FORM 8-K
8-K	Aug 6, 2026	FORM 8-K
8-K	Aug 4, 2026	FORM 8-K
8-K	Jul 7, 2026	FORM 8-K
DEF 14A	Jun 29, 2026	DEF 14A
ARS	Jun 29, 2026	ARS
PRE 14A	Jun 18, 2026	PRE 14A
8-K	Jun 11, 2026	FORM 8-K
8-K	Jun 5, 2026	FORM 8-K
10-Q	May 5, 2026	10-Q
8-K	May 5, 2026	FORM 8-K
DEF 14A	Apr 30, 2026	DEF 14A
PRE 14A	Apr 20, 2026	PRE 14A
8-K	Apr 17, 2026	FORM 8-K
8-K	Apr 9, 2026	FORM 8-K
8-K	Mar 23, 2026	FORM 8-K
DEF 14A	Mar 16, 2026	DEF 14A
10-K	Mar 12, 2026	10-K
8-K	Mar 12, 2026	FORM 8-K
PRE 14A	Mar 4, 2026	PRE 14A

← Newer Page 1 of 40 · 977 filings Older →